Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$139.74

-1.36 (-0.96%)

16:11
12/10/18
12/10
16:11
12/10/18
16:11

Jazz Pharmaceuticals announces $400M increase to share repurchase program

Jazz Pharmaceuticals announced that its Board of Directors has authorized a $400M increase in the company's share repurchase program, which the company intends to use over time based on market conditions and other factors. Prior to this increased authorization, the Board of Directors had authorized $620M under the company's share repurchase program, of which $194M had been utilized through September 30, 2018. Since that date, the company has utilized the remainder of that prior authorization.

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$139.74

-1.36 (-0.96%)

11/27/18
RBCM
11/27/18
NO CHANGE
RBCM
RBC Capital likes select Specialty Pharma names on recent sector selling
RBC Capital analyst Randall Stanicky is positive on Amneal Pharmaceuticals (AMRX), Endo International (ENDP), Flexion Therapeutics (FLXN), Jazz Pharmaceuticals (JAZZ) as his top selections in Specialty Pharma, saying the sector has come under particular pressure in the most recent market sell-off. The analyst anticipates Amneal Pharmaceuticals to benefit from a cyclical generics recovery in the 2nd half of 2019, saying its "valuation is compelling against growth outlook". For Endo International, Stanicky sees the cellulite data driven selloff as overdone and believes that its low valuation helps to set a floor for the stock. For Flexion, the analyst anticipates a 2019 inflection on ramping Zilretta launch, adding that its 32% short interest is "hard to ignore". For Jazz Pharma, Stanicky points to a re-set of expectations around Vyxeos in Q3 as the company enters a "catalyst-heavy path led by December 20th solriamfetol PDUFA" and a material discount in valuation. The analyst maintain his Outperform rating on these four stocks.
11/20/18
MZHO
11/20/18
NO CHANGE
Target $157
MZHO
Neutral
Jazz Pharmaceuticals price target lowered to $157 from $173 at Mizuho
Mizuho analyst Irina Koffler lowered her price target for Jazz Pharmaceuticals to $157 citing the company's "disappointing" quarter, "weak" commercial execution on newly launched Vyxeos, and "more persistent" Erwinaze supply disruption that is not expected to improve. The analyst keeps a Neutral rating on the shares.
11/07/18
RBCM
11/07/18
NO CHANGE
Target $184
RBCM
Outperform
Jazz Pharmaceuticals price target lowered to $184 from $194 at RBC Capital
RBC Capital analyst Randall Stanicky lowered his price target on Jazz Pharmaceuticals to $184 after its Q3 results, saying the company again "missed the mark" on Vyxeos whose launch continues to disappoint. The analyst keeps his Outperform rating on Jazz Pharmaceuticals, citing the "robust" 9% volume growth for Xyrem and its anticipated near-term launches, but believes that unlocking value for investors may take "longer than anticipated".
10/19/18
PIPR
10/19/18
NO CHANGE
Target $213
PIPR
Overweight
Jazz shares could rally over $250 with JZP-258 success, says Piper Jaffray
After taking a closer look at the potential impact of JZP-258, Jazz Pharmaceuticals' form of oxybate for narcolepsy, Piper Jaffray analyst David Amsellem reiterates an Overweight rating on the shares with a $213 price target. If JZP-258 were to capture a significant share of the oxybate market, that would translate into not only limited erosion of cash flows from Jazz's oxybate franchise, but also a "significant re-rating of valuation multiples" for Jazz, Amsellem tells investors in a research note. He believes a scenario involving greater than 50% market share for JZP-258 would translate into a value per share of north of $250. Further, the downside risk to the shares in a scenario with limited or no contribution from JZP-258 is "far more limited than the upside potential," contends Amsellem.

TODAY'S FREE FLY STORIES

AAPL

Apple

$264.06

2.17 (0.83%)

, NFLX

Netflix

$286.81

-5.2 (-1.78%)

12:57
11/13/19
11/13
12:57
11/13/19
12:57
Recommendations
Apple, Netflix, Disney analyst commentary  »

Disney's 'jaw…

AAPL

Apple

$264.06

2.17 (0.83%)

NFLX

Netflix

$286.81

-5.2 (-1.78%)

DIS

Disney

$143.25

4.69 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

CRK

Comstock Resources

$7.02

0.14 (2.03%)

, CHK

Chesapeake

$0.71

0.0412 (6.15%)

12:51
11/13/19
11/13
12:51
11/13/19
12:51
Hot Stocks
Chesapeake shares pop on asset sale talks as analyst comments on debt covenant »

Shares of natural gas…

CRK

Comstock Resources

$7.02

0.14 (2.03%)

CHK

Chesapeake

$0.71

0.0412 (6.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:50
11/13/19
11/13
12:50
11/13/19
12:50
General news
Treasury Action: both bonds and stocks are bullish today »

Treasury Action: both…

NTAP

NetApp

$60.60

0.48 (0.80%)

12:48
11/13/19
11/13
12:48
11/13/19
12:48
Earnings
Fly Intel: What to watch in NetApp's earnings report »

NetApp (NTAP) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 20

    Nov

  • 12

    Dec

WHR

Whirlpool

$150.00

-5.36 (-3.45%)

12:45
11/13/19
11/13
12:45
11/13/19
12:45
Options
Whirlpool call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,299.26

2.08 (0.16%)

, GOOG

Alphabet

$1,301.02

2.25 (0.17%)

12:40
11/13/19
11/13
12:40
11/13/19
12:40
On The Fly
#SocialStocks: Instagram hiding likes in U.S., Tik Tok challenging Facebook ads »

Welcome to…

GOOGL

Alphabet Class A

$1,299.26

2.08 (0.16%)

GOOG

Alphabet

$1,301.02

2.25 (0.17%)

FB

Facebook

$193.29

-1.18 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
11/13/19
11/13
12:40
11/13/19
12:40
General news
Powell's testimony has ended »

Powell's testimony…

AVP

Avon Products

$4.47

-0.075 (-1.65%)

12:39
11/13/19
11/13
12:39
11/13/19
12:39
Hot Stocks
Avon Products shareholders approve proposed acquisition by Natura »

Avon Products announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LJPC

La Jolla

$6.81

0.11 (1.64%)

12:36
11/13/19
11/13
12:36
11/13/19
12:36
Recommendations
La Jolla analyst commentary  »

La Jolla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$59.33

-0.01 (-0.02%)

, NFLX

Netflix

$290.50

-1.51 (-0.52%)

12:31
11/13/19
11/13
12:31
11/13/19
12:31
Hot Stocks
Disney rallies after announcing 10M streaming sign-ups »

Shares of Walt Disney…

VZ

Verizon

$59.33

-0.01 (-0.02%)

NFLX

Netflix

$290.50

-1.51 (-0.52%)

DIS

Disney

$140.90

2.34 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 30

    Jan

GOOGL

Alphabet Class A

$1,299.86

2.68 (0.21%)

, C

Citi

$74.61

-0.47 (-0.63%)

12:31
11/13/19
11/13
12:31
11/13/19
12:31
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks looked in…

GOOGL

Alphabet Class A

$1,299.86

2.68 (0.21%)

C

Citi

$74.61

-0.47 (-0.63%)

NKE

Nike

$90.55

1.04 (1.16%)

AMZN

Amazon.com

$1,762.55

-15.78 (-0.89%)

DKS

Dick's Sporting

$40.24

-0.01 (-0.02%)

GOOG

Alphabet

$1,300.57

1.8 (0.14%)

AAPL

Apple

$264.06

2.17 (0.83%)

GS

Goldman Sachs

$218.71

-1.7 (-0.77%)

TECD

Tech Data

$131.30

5.91 (4.71%)

APO

Apollo Global

$42.95

0.015 (0.03%)

DDOG

Datadog

$39.87

5.47 (15.90%)

CDLX

Cardlytics

$52.02

12.17 (30.54%)

LK

Luckin Coffee

$21.32

2.32 (12.21%)

CSIQ

Canadian Solar

$15.39

-2.12 (-12.11%)

SDC

SmileDirectClub

$9.02

-2 (-18.15%)

I

Intelsat

$13.93

-6.46 (-31.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 04

    Dec

  • 09

    Dec

  • 10

    Dec

  • 14

    Jan

CSCO

Cisco

$48.63

0.25 (0.52%)

, ACIA

Acacia Communications

$67.39

0.11 (0.16%)

12:27
11/13/19
11/13
12:27
11/13/19
12:27
On The Fly
Fly Intel: What to watch in Cisco's earnings report »

Cisco (CSCO) is scheduled…

CSCO

Cisco

$48.63

0.25 (0.52%)

ACIA

Acacia Communications

$67.39

0.11 (0.16%)

DDOG

Datadog

$39.79

5.39 (15.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

  • 09

    Dec

  • 10

    Dec

IRTC

iRhythm

$61.56

-5.885 (-8.73%)

12:25
11/13/19
11/13
12:25
11/13/19
12:25
Recommendations
iRhythm analyst commentary  »

iRhythm filing delay not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:20
11/13/19
11/13
12:20
11/13/19
12:20
General news
Powell on China growth: very hard to understand China »

Powell on China growth:…

12:20
11/13/19
11/13
12:20
11/13/19
12:20
General news
Oil Action: WTI crude »

Oil Action: WTI crude is…

IRTC

iRhythm

$61.02

-6.425 (-9.53%)

12:19
11/13/19
11/13
12:19
11/13/19
12:19
Recommendations
iRhythm analyst commentary  »

iRhythm shares likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$61.02

-6.42 (-9.52%)

12:19
11/13/19
11/13
12:19
11/13/19
12:19
Hot Stocks
iRhythm sinks after additional errors leads to quarterly filing delay »

Shares of iRhythm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/13/19
11/13
12:17
11/13/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/13/19
11/13
12:16
11/13/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STNE

StoneCo

$35.85

-0.15 (-0.42%)

12:15
11/13/19
11/13
12:15
11/13/19
12:15
Options
StoneCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

12:15
11/13/19
11/13
12:15
11/13/19
12:15
General news
Powell: the outlook is still positive and there's no reason why the expansion cannot continue »

Powell: the outlook is…

12:15
11/13/19
11/13
12:15
11/13/19
12:15
General news
Breaking General news story  »

Richmond Federal Reserve…

12:15
11/13/19
11/13
12:15
11/13/19
12:15
General news
Breaking General news story  »

Richmond Federal Reserve…

ACCO

Acco Brands

$9.34

-0.02 (-0.21%)

12:13
11/13/19
11/13
12:13
11/13/19
12:13
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

INVE

Identiv

$4.92

-0.08 (-1.60%)

12:08
11/13/19
11/13
12:08
11/13/19
12:08
Hot Stocks
Identiv partners with GTSC to address 'evolving threats' to U.S. agencies »

Identiv announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.